Skip to content

Fallopian tube recanalization combined with lipiodol infusion

Fallopian tube recanalization combined with lipiodol infusion

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063543
Enrollment
Unknown
Registered
2022-09-10
Start date
2022-09-10
Completion date
Unknown
Last updated
2023-04-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tubal infertility

Interventions

Iodized oil infusion group:Fallopian tube recanalization combined with lipiodol infusion
Routine fallopian tube recanalization group:Conventional fallopian tube recanalization

Sponsors

Nanjing Maternal and Child Health Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
22 Years to 39 Years

Inclusion criteria

Inclusion criteria: 1. Age 22-39 years; 2. Female infertility patients who live together with husband and wife, have regular menstruation, and have not been pregnant for 1 year or more without contraception; 3. Hysterosalpingography diagnosed as the abnormal degree of tubal patency (HSG indicates that the tubal patency is not smooth, the tubal patency is extremely poor, obstruction or mild adhesion at the distal end); 4. There was no significant abnormality in the semen indexes of spouses; 5. Those who voluntarily received FTR treatment.

Exclusion criteria

Exclusion criteria: 1. One side of the fallopian tube is normal in shape (HSG indicates that the fallopian tube is unobstructed and there is no clear abnormality in its course); 2. Infertility with other factors; 3. Have a history of tubal pregnancy; 4. The fallopian tube lumen was obviously dilated and thickened, and the fimbrial end was severely adhered and blocked; 5. History of tubal or ovarian surgery; 6. FTR operation contraindication; 7. Those who received ovulation induction and artificial insemination during the follow-up period; 8. FTR technology fails; 9. Those who cannot cooperate to complete the follow-up.

Design outcomes

Primary

MeasureTime frame
Pregnancy rate;Ectopic pregnancy rate;Spontaneous abortion rate;Fallopian tube patency rate;Time required for pregnancy;

Countries

China

Contacts

Public ContactLu Jingyuan

Nanjing Maternal and Child Health Hospital

ljyxy249@qq.com+86 13913821547

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026